Photo taken from Jim Olson/LinkedIn
Sep 22, 2023, 18:13
Jim Olson: Bittersweet day as we held the final meeting of the National Cancer Institute (NCI) Moonshot Pediatric Immunotherapy Drug Development Network
Jim Olson, Principal Investigator at Seattle Children’s Research Institute, shared on LinkedIn:
“Bittersweet day as we held the final meeting of the National Cancer Institute (NCI) Moonshot Pediatric Immunotherapy Drug Development Network. Amazing consortium that is advancing multiple therapies into pediatric clinical trials. Our team presented work on bispecific antibodies that show excellent preclinical activity in models of a rare and aggressive form of leukemia (CBF:GLIS) that affects infants and toddlers.”
Source: Jim Olson/LinkedIn
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 21, 2024, 21:47
Nov 21, 2024, 21:40
Nov 21, 2024, 21:36
Nov 21, 2024, 21:27
Nov 21, 2024, 21:23
Nov 21, 2024, 21:17
Nov 21, 2024, 21:07
Nov 21, 2024, 17:57